A carregar...
HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer
BACKGROUND: The clinical significance of intratumoral human epidermal growth factor receptor 2 (HER2) heterogeneity is unclear for HER2-positive gastric cancer, although it has been reported to be a significant prognosticator for HER2-positive breast cancer, which has received trastuzumab-based chem...
Na minha lista:
| Publicado no: | World J Clin Cases |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6695545/ https://ncbi.nlm.nih.gov/pubmed/31423428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v7.i15.1964 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|